Leukemia Myeloid Acute
📧 Sign up to get email alerts when something new happens for Leukemia Myeloid Acute.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Results: Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation [NA]
A completed clinical trial evaluating an electronic mindfulness-based music therapy intervention for patients undergoing allogeneic stem cel…
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) [Phase 1, Phase 2]
Phase 1/2 clinical trial update on NK donor lymphocyte infusion following HLA-haploidentical HSCT; study status completed.
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: A Study of Pevonedistat in Adult East Asian Participants [Phase 1]
Phase 1 trial update of pevonedistat in adult East Asian participants has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia [Phase 3]
Phase 3 trial comparing Iomab-B to conventional care in older patients with active, relapsed or refractory acute myeloid leukemia is ongoing…
-
CLINICAL_TRIALS trial_result · 2022-07-13Clinical Trial Update: Prophylactic Application of Donor-derived TCM After Allogeneic HSCT [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigated prophylactic use of donor-derived TCM after allogeneic hematopoietic stem cell transplantation, comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML) [Phase 2]
Phase 2 trial evaluating pevonedistat plus azacitidine versus azacitidine alone in higher-risk myelodysplastic syndromes, chronic myelomonoc…
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Prophylactic DLI for the Prevention of Relapse Post HSCT in Patients With High Risk Myeloid Malignancy [Phase 2]
Phase 2 clinical trial evaluating prophylactic donor lymphocyte infusion to prevent relapse after allogeneic stem cell transplant in high-ri…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating decitabine in combination with mBU/CY for high-risk acute leukemia with minimal residual disease before …
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation [Phase 1, Phase 2]
Phase 1/2 clinical trial of azacitidine in patients undergoing matched unrelated donor stem cell transplantation has been terminated; result…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies [Phase 2]
Phase 2 clinical trial update on mismatched family member donor stem cell transplantation in children and young adults with high-risk hemato…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) [Phase 3]
Phase 3 trial comparing sirolimus/tacrolimus versus tacrolimus/methotrexate for GVHD prevention in transplantation; study completed with res…
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation [NA]
Clinical trial update on mismatched donor lymphocyte infusions for relapse after allogeneic stem cell transplantation; status completed with…
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603) [Phase 2]
Phase 2 clinical trial update on bone marrow transplantation from partially matched donors with nonmyeloablative conditioning for various bl…
-
CLINICAL_TRIALS trial_result · 2015-08-28Clinical Trial Update: Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604) [Phase 2]
Phase 2 clinical trial evaluating safety and effectiveness of an umbilical cord blood stem cell transplant for various hematologic malignanc…
-
CLINICAL_TRIALS trial_result · 2008-11-18Clinical Trial Update: Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H [Phase 1]
A Phase 1 study evaluating the feasibility of haploidentical hematopoietic stem cell transplantation using CAMPATH-1H in acute myeloid leuke…